Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis
Background: The lack of effective serum and cerebrospinal fluid (CSF) biomarkers remains a barrier to early diagnosis and treatment of multiple sclerosis (MS). The study is to identify the diagnostic biomarkers of serum and CSF in patients who suffered MS.Methods: At first, we performed differential...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2022-04-01
|
| シリーズ: | Frontiers in Genetics |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fgene.2022.892491/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|